Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Collaborations Pharma Logo
Collaborations Pharma Growth Score
54
CB Rank
158343
Heat Score
60
Performs research and development on innovative therapeutics for multiple rare and infectious diseases.
Founded
obfuscation
PrivateGrant Raleigh, North Carolina, United States11-50 www.collaborationspharma.com
Biotechnology
Pharmaceutical
Overview

Collaborations Pharma
Total Funding
obfuscation
Growth Score
54
Heat Score
60

Total Funding
obfuscation
obfuscation
Grant raised
obfuscation
Growth Score54
-21 pts
in past quarter
Heat Score 60
-7 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Collaborations Pharma

CB Rank
158343
Performs research and development on innovative therapeutics for multiple rare and infectious diseases.
Founded
obfuscation
PrivateGrant Raleigh, North Carolina, United States11-50 www.collaborationspharma.com
Biotechnology
Pharmaceutical

Funding Rounds

Grant
OBF
in
obfuscation

Key People

Details

Legal Name Collaborations Pharmaceuticals, Inc.
Operating Status Active
Company Type For Profit
Founders  Sean Ekins
About the Company
Performs research and development on innovative therapeutics for multiple rare and infectious diseases.
Predictions & Insights

Growth Insight

See this Growth Insight
Collaborations Pharma is
Lorem
 to be growing
Top Contributing Factors
Recently Raised Funding

Growth Prediction

See this Growth Prediction

Products & Services

Recombinant Human Enzyme Replacement Therapy for Batten Disease CLN1
A protein therapy designed to replace deficient enzyme in patients with Batten Disease CLN1, delivered via intracerebroventricular (ICV) administration.
Assay Central® Machine Learning Platform
A platform for creating and building machine learning models to predict molecular properties and bioactivities.

Research & Development

Collaborations Pharma is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
...

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Grant - Collaborations Pharma Logo
Grant - Collaborations Pharma
1
obfuscation
One North Carolina Small Business ProgramGrant
obfuscation
Grant - Collaborations Pharma Logo
Grant - Collaborations Pharma
1
obfuscation
One North Carolina Small Business ProgramGrant
obfuscation
Grant - Collaborations Pharma Logo
Grant - Collaborations Pharma
1
obfuscation
One North Carolina Small Business ProgramGrant
obfuscation
Grant - Collaborations Pharma Logo
Grant - Collaborations Pharma
1
obfuscation
One North Carolina Small Business ProgramGrant
obfuscation
Grant - Collaborations Pharma Logo
Grant - Collaborations Pharma
1
obfuscation
One North Carolina Small Business ProgramGrant

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Grant - Collaborations Pharma Logo
Grant - Collaborations Pharma
1
obfuscation
One North Carolina Small Business ProgramGrant
obfuscation
Grant - Collaborations Pharma Logo
Grant - Collaborations Pharma
1
obfuscation
One North Carolina Small Business ProgramGrant
obfuscation
Grant - Collaborations Pharma Logo
Grant - Collaborations Pharma
1
obfuscation
One North Carolina Small Business ProgramGrant
obfuscation
Grant - Collaborations Pharma Logo
Grant - Collaborations Pharma
1
obfuscation
One North Carolina Small Business ProgramGrant
obfuscation
Grant - Collaborations Pharma Logo
Grant - Collaborations Pharma
1
obfuscation
One North Carolina Small Business ProgramGrant

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 11-50 Employee Profiles 1 Contacts 10

Employee Profiles

News

News and Press

News•Jan 16, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Nov 19, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Oct 7, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Oct 9, 2024
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

704
3,590.52%
 in past month

IT Spend

$68.8KThis year, Collaborations Pharma is projected to spend $68.8K on IT, according to Aberdeen.

Interest Signals

TopicSurge Score
ChatGPT-4 Logo
ChatGPT-4
73
Research and Development / Test Logo
Research and Development / Test
72

Active Website Tech Count

19Collaborations Pharma is actively using 19 technologies for its website, according to BuiltWith. These include Apple Mobile Web Clips Icon, DNSSEC, and  nginx.

Total IP

18The intellectual property of Collaborations Pharma includes 12 registered patents primarily in the 'Medical Or Veterinary Science; Hygiene' category, according to IPqwery. Additionally, Collaborations Pharma has registered 6 trademarks with the most popular class being 'Scientific and technological services', according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Collaborations Pharma's headquarters? Collaborations Pharma is located in Raleigh, North Carolina, United States.Who invested in Collaborations Pharma? Collaborations Pharma is funded by One North Carolina Small Business Program.When was the last funding round for Collaborations Pharma? Collaborations Pharma closed its last funding round on
obfuscation
from a Grant round.Who are Collaborations Pharma's competitors? Alternatives and possible competitors to Collaborations Pharma may include BioMarin Pharmaceutical, Denali Therapeutics, and  Ionis Pharmaceuticals.How much funding has Collaborations Pharma raised to date? Collaborations Pharma has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(b82cf0e 1)
|